Logo do repositório
 
Publicação

Drug use in pregnant women of Mirandela, Macedo de Cavaleiros and Bragança

2018Documento de conferência Acesso aberto
Ver registo simples
dc.contributor.authorBranco, Ana Laura
dc.contributor.authorCoutinho, Ana
dc.contributor.authorMachado, Ana
dc.contributor.authorAlves, Bárbara
dc.contributor.authorNascimento, Luís
dc.contributor.authorPereira, Olívia R.
dc.date.accessioned2018-11-05T16:47:35Z
dc.date.available2018-11-05T16:47:35Z
dc.date.issued2018
dc.description.abstractThe use of drugs during the gestational period is a subject of great concern once the exposure of medicines may result in toxicities with possible irreversible lesions for fetus. In fact, drugs in pregnancy have been restricted since the accident of thalidomide. In 1979 the U.S. Food and Drug Administration (FDA) adopts the classification of drugs as the risk associated with their use during pregnancy, these being classified into 5 classes (A, B, C, D and X). The aim of the present study was to characterize the use of drug therapy in pregnant women of of Mirandela, Macedo de Cavaleiros and Bragança regions. A cross-sectional study was performed through application of a questionnaire to 134 pregnant women in the Northeast (Mirandela, Macedo de Cavaleiros and Bragança regions) during a consultation in a health center. Descriptive statistics were used, as well as univariate and multivariate statistical analysis, with significance level of 5%. The sample was comprised of a total of 134 pregnant women in the Northeast area mostly with ages between 21 and 30 years or between 31 and 40 years (56.7% and 35.8%, respectively), secondary or higher education (48.5% and 42.5%, respectively) and employed (67.2%). About half of pregnant (47.8%) were in the 3rd quarter of pregnancy. 78.4% (105 women) of the pregnant have been used drugs during the pregnancy, 64.4% after medical prescription, and 71.6% have acquired the medication at the pharmacy. In detail, the medication most used was folic acid (64.2%, 86 of the pregnant women) belongs to class A, paracetamol from class B (35.1%, n= 47), iodine (17.2%, n=23) and iron (14.9%, n=20), both belonging to the class A. Less reported drugs have included metoclopramide (6.0%) and Vitamin D3 (6.0%), from Class C and Class D, respectively. It is important to refer that 12.7% of women had a chronic disease and 2.2% have an acute disease during the pregnancy. The diseases more reported were asthma and diabetes. In the present study, the use of drugs in pregnancy was independent of the education level, chronic or acute disease, locality, marital status, employment status, gestational period and health center. The drugs most used by pregnant women belong to class A (18.5%), class B (25.9%) and class C (33.3%) and the less used belong to class D and X. Supplements such as folic acid, iodine and iron and the analgesic paracetamol were the most reported.pt_PT
dc.description.versioninfo:eu-repo/semantics/publishedVersionpt_PT
dc.identifier.citationBranco, Ana; Coutinho, Ana; Machado, Ana; Alves, Bárbara; Nascimento, Luís; Pereira, Olívia R. (2018). Drug use in pregnant women of Mirandela, Macedo de Cavaleiros and Bragança. In Proceedings of the 4th IPLeiria’s International Health Congress e BMC Health Services Research. 18(Suppl 2):684, p. 48pt_PT
dc.identifier.urihttp://hdl.handle.net/10198/18145
dc.language.isoengpt_PT
dc.peerreviewedyespt_PT
dc.publisherBMC Health Services Researchpt_PT
dc.rights.urihttp://creativecommons.org/licenses/by/4.0/pt_PT
dc.subjectPregnancypt_PT
dc.subjectDrug therapypt_PT
dc.subjectRiskpt_PT
dc.titleDrug use in pregnant women of Mirandela, Macedo de Cavaleiros and Bragançapt_PT
dc.typeconference object
dspace.entity.typePublication
oaire.citation.conferencePlaceLeiriapt_PT
oaire.citation.issueS2pt_PT
oaire.citation.startPage48pt_PT
oaire.citation.titleProceedings of the 4th IPLeiria’s International Health Congresspt_PT
oaire.citation.volume18pt_PT
person.familyNameNascimento
person.familyNamePereira
person.givenNameLuís
person.givenNameOlívia R.
person.identifier145216
person.identifier.ciencia-id9918-ED25-623E
person.identifier.ciencia-idB312-AF21-D2FA
person.identifier.orcid0000-0002-1302-2570
person.identifier.orcid0000-0002-6275-3134
person.identifier.ridH-1049-2014
person.identifier.scopus-author-id52264387000
rcaap.rightsopenAccesspt_PT
rcaap.typeconferenceObjectpt_PT
relation.isAuthorOfPublication9e7bebc0-4460-4f4c-b687-10e34c3b36b9
relation.isAuthorOfPublicatione8fdab9a-3ad6-47e6-b90c-7a37aabcb453
relation.isAuthorOfPublication.latestForDiscoverye8fdab9a-3ad6-47e6-b90c-7a37aabcb453

Ficheiros

Principais
A mostrar 1 - 1 de 1
Miniatura indisponível
Nome:
Ana et al_PregnantMedication_2018_Abstract_BMC.pdf
Tamanho:
437.06 KB
Formato:
Adobe Portable Document Format
Ver/Abrir
Licença
A mostrar 1 - 1 de 1
Miniatura indisponível
Nome:
license.txt
Tamanho:
1.75 KB
Formato:
Item-specific license agreed upon to submission
Descrição:
Ver/Abrir

Coleções

CIMO - Resumos em Proceedings Não Indexados à WoS/Scopus